The University Clinical Centre in Gdańsk is the main teaching hospital at the Medical University of Gdańsk. It is a multi-speciality hospital, the largest in the north of Poland and one of the largest in the country.

During the past decade, Uniwersyteckie Centrum Kliniczne Klinika Onkologii i Radioterapii conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 17 clinical trials were completed, i.e. on average, 47.2% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 10 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Uniwersyteckie Centrum Kliniczne Klinika Onkologii i Radioterapii" #1 sponsor was "Hoffmann-La Roche" with 29 trials, followed by "Pfizer" with 4 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Institut de Recherches Internationales Servier" with 2 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Uniwersyteckie Centrum Kliniczne Klinika Onkologii i Radioterapii" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator and "GORTEC (Head and Neck Oncology and Radiotherapy Group)" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Uniwersyteckie Centrum Kliniczne Klinika Onkologii i Radioterapii" are "Breast Cancer" (7 trials), "Non-Small Cell Lung Cancer" (5 trials), "Melanoma" (3 trials), "Breast Neoplasms" (2 trials) and "Cancer" (2 trials). Many other conditions were trialed in "Uniwersyteckie Centrum Kliniczne Klinika Onkologii i Radioterapii" in a lesser frequency.

Most popular intervention types in "Uniwersyteckie Centrum Kliniczne Klinika Onkologii i Radioterapii" are "Drug" (39 trials), "Other" (3 trials), "Biological" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (14 trials), "Placebo" (12 trials), "Docetaxel" (6 trials), "Carboplatin" (5 trials) and "Alectinib" (4 trials). Other intervention names were less common.

The vast majority of trials in "Uniwersyteckie Centrum Kliniczne Klinika Onkologii i Radioterapii" are 37 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Uniwersyteckie Centrum Kliniczne Klinika Onkologii i Radioterapii". undefined are not yet recruiting, 9 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Uniwersyteckie Centrum Kliniczne Klinika Onkologii i Radioterapii, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Uniwersyteckie Centrum Kliniczne Klinika Onkologii i Radioterapii, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".